Autologous fat grafting for reconstructive surgery a review of the clinical and cost-effectiveness

Each year, approximately 22,000 Canadian women receive surgical treatment for breast cancer. Of those women who have undergone a mastectomy for unilateral invasive cancer, close to one in 10 also undergoes reconstructive surgery. Autologous fat transfer, or fat grafting, is a reconstructive interven...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: [Ottawa] Canadian Agency for Drugs and Technologies in Health 26 May 2014, 2014
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 03148nam a2200301 u 4500
001 EB001029817
003 EBX01000000000000000823370
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150411 r ||| eng
245 0 0 |a Autologous fat grafting for reconstructive surgery  |h Elektronische Ressource  |b a review of the clinical and cost-effectiveness 
260 |a [Ottawa]  |b Canadian Agency for Drugs and Technologies in Health  |c 26 May 2014, 2014 
300 |a 1 PDF file (18 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Comparative Effectiveness Research 
653 |a Neoplasm Recurrence, Local 
653 |a Transplantation, Autologous 
653 |a Adipose Tissue / transplantation 
653 |a Mammaplasty / methods 
653 |a Breast Neoplasms / surgery 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Rapid response report: summary with critical appraisal 
500 |a Title from PDF caption title 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK263339  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 580 
520 |a Each year, approximately 22,000 Canadian women receive surgical treatment for breast cancer. Of those women who have undergone a mastectomy for unilateral invasive cancer, close to one in 10 also undergoes reconstructive surgery. Autologous fat transfer, or fat grafting, is a reconstructive intervention that has been used since the late 1800s to correct tissue deformities in several areas of the body, including the face. Fat is removed from one part of the body through liposuction, purified by centrifugation, and reinjected into another area of the body. Autologous treatments are inherently appealing because of the use of a patient's own tissue, and fat grafting is conceptually and technically straightforward while bearing the potential to be repeated if necessary. Autologous fat grafting for breast reconstruction was introduced in the 1980s, but was soon discouraged due to concerns about calcified grafted tissue compromising imaging detection of abnormal breast lesions. However, interest in this procedure subsequently increased with the advent of the Coleman technique for structural fat grafting that was associated with improved graft survival and tissue regeneration. One point still under study and debate is the suggestion that the regenerative potential of tissue implanted in a site of previous cancer may increase the risk of cancer recurrence. Some concerns regarding the safety and effectiveness of autologous fat grafting remain and it is not a universally recommended method of breast reconstruction following oncologic surgery. With its increasing popularity and in the light of this uncertainty, questions have arisen about autologous fat grafting. The objective of this review is to evaluate the clinical benefit of autologous fat grafting, aside from cosmetic improvement, for reconstructive surgery and to identify any safety issues and costs associated with the procedure